Research and experimental development on natural sciences and engineering
ACD PHARMACEUTICALS AS
Revenue 2024
NOK 24.7m
Operating profit
NOK −3.8m
Equity
NOK 14.0m
Incorporated
1997
Employees
10
Share capital
NOK 10.0m
Key figures · 2024
Current ratio
0.44
Equity ratio
18.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -15.5% | |
| Net margin (%%) | -3.9% | |
| Return on assets (%%) | -5.1% | |
| Likviditet | ||
| Current ratio | 0.44 | |
| Working capital | −34.3m | |
| Soliditet | ||
| Equity ratio (%%) | 18.5% | |
| Debt-to-equity ratio | 4.40 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.